Peritoneal Serous Papillary Adenocarcinoma: Report of Four Cases

We report four cases of peritoneal serous papillary adenocarcinoma (PSPC), a rare disease; all patients had ascites and high levels of serum CA125. Clinical and radiological examinations could not differentiate the disease from peritoneal metastatic tumors and mesothelioma, and histopathological ana...

Full description

Saved in:
Bibliographic Details
Published inInternal Medicine Vol. 44; no. 9; pp. 944 - 948
Main Authors TSUJIMURA, Takahiro, MINAMI, Takeshi, NAKATANI, Koji, KONDO, Shinya, KANAYAMA, Shuji
Format Journal Article
LanguageEnglish
Published Tokyo The Japanese Society of Internal Medicine 01.09.2005
Japanese Society of Internal Medicine
Subjects
Adult
Aged
Biological and medical sciences
Biomarkers, Tumor - metabolism
CA-125 Antigen - metabolism
chemotherapy
Cystadenocarcinoma, Papillary - diagnosis
Cystadenocarcinoma, Papillary - metabolism
Cystadenocarcinoma, Papillary - pathology
Diagnosis, Differential
Female
General aspects
Humans
Immunohistochemistry
Medical sciences
Mesothelioma - diagnosis
Middle Aged
Peritoneal Neoplasms - diagnosis
Peritoneal Neoplasms - metabolism
Peritoneal Neoplasms - pathology
peritoneum
Prognosis
Antineoplastic agent
Case study
Human
Immunohistochemistry
Anatomic pathology
Chemotherapy
Papillary adenocarcinoma
Treatment
Internal medicine
Abdominal disease
Malignant tumor
Peritoneum
Online AccessGet full text
ISSN0918-2918
1349-7235
1349-7235
DOI10.2169/internalmedicine.44.944

Cover

Abstract We report four cases of peritoneal serous papillary adenocarcinoma (PSPC), a rare disease; all patients had ascites and high levels of serum CA125. Clinical and radiological examinations could not differentiate the disease from peritoneal metastatic tumors and mesothelioma, and histopathological analysis including immunochemistry on the specimen obtained at laparotomy or laparoscopy was necessary for the diagnosis. One patient lived for 58 months with cytoreductive surgery and chemotherapy, and another is still living after 20 months by chemotherapy alone. In patients with peritoneal tumors of unknown origin and a high level of serum CA125, taking PSPC into consideration in the differential diagnosis, histopathological examination should be performed.
AbstractList We report four cases of peritoneal serous papillary adenocarcinoma (PSPC), a rare disease; all patients had ascites and high levels of serum CA125. Clinical and radiological examinations could not differentiate the disease from peritoneal metastatic tumors and mesothelioma, and histopathological analysis including immunochemistry on the specimen obtained at laparotomy or laparoscopy was necessary for the diagnosis. One patient lived for 58 months with cytoreductive surgery and chemotherapy, and another is still living after 20 months by chemotherapy alone. In patients with peritoneal tumors of unknown origin and a high level of serum CA125, taking PSPC into consideration in the differential diagnosis, histopathological examination should be performed.We report four cases of peritoneal serous papillary adenocarcinoma (PSPC), a rare disease; all patients had ascites and high levels of serum CA125. Clinical and radiological examinations could not differentiate the disease from peritoneal metastatic tumors and mesothelioma, and histopathological analysis including immunochemistry on the specimen obtained at laparotomy or laparoscopy was necessary for the diagnosis. One patient lived for 58 months with cytoreductive surgery and chemotherapy, and another is still living after 20 months by chemotherapy alone. In patients with peritoneal tumors of unknown origin and a high level of serum CA125, taking PSPC into consideration in the differential diagnosis, histopathological examination should be performed.
We report four cases of peritoneal serous papillary adenocarcinoma (PSPC), a rare disease; all patients had ascites and high levels of serum CA125. Clinical and radiological examinations could not differentiate the disease from peritoneal metastatic tumors and mesothelioma, and histopathological analysis including immunochemistry on the specimen obtained at laparotomy or laparoscopy was necessary for the diagnosis. One patient lived for 58 months with cytoreductive surgery and chemotherapy, and another is still living after 20 months by chemotherapy alone. In patients with peritoneal tumors of unknown origin and a high level of serum CA125, taking PSPC into consideration in the differential diagnosis, histopathological examination should be performed.
Author TSUJIMURA, Takahiro
MINAMI, Takeshi
NAKATANI, Koji
KANAYAMA, Shuji
KONDO, Shinya
Author_xml – sequence: 1
  fullname: TSUJIMURA, Takahiro
  organization: Department of Pathology, Sumitomo Hospital, Osaka
– sequence: 1
  fullname: MINAMI, Takeshi
  organization: Department of Gastroenterology, Sumitomo Hospital, Osaka
– sequence: 1
  fullname: NAKATANI, Koji
  organization: Department of Gastroenterology, Sumitomo Hospital, Osaka
– sequence: 1
  fullname: KONDO, Shinya
  organization: Department of Gastroenterology, Sumitomo Hospital, Osaka
– sequence: 1
  fullname: KANAYAMA, Shuji
  organization: Department of Gastroenterology, Sumitomo Hospital, Osaka
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17226221$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/16258208$$D View this record in MEDLINE/PubMed
BookMark eNqVkE1rFTEUhoNU7G31L-hsdDfXTJKZzAiC5dJW4UJL1XU4zZxoSm4yJhlK_31T5tJCcaGbczbPcz7eI3Lgg0dC3jV0zZpu-Gh9xujB7XC02npcC7EehHhBVg0XQy0Zbw_Iig5NX7NSDslRSjeU8l4O7BU5bDrW9oz2K_LlEqPNZTi46jvGMKfqEibrHMS76mREHzTEsiHs4FN1hVOIuQqmOgtzrDaQML0mLw24hG_2_Zj8PDv9sflaby_Ov21OtrXuaJdrSekwyHI6INfatEZ2bQtigNGMTF-LvjXITC85UgFMdjjKBlDynmIrkRt-TPpl7uwnuLsF59QU7a6cqRqqHkJRz0NRQqgSSlE_LOoUw58ZU1Y7mzSWHz2Wh1XXS9G19AF8uwfn6zLkacE-rgK83wOQNDgTwWubnjjJWMdYUzi5cDqGlCKa_7j18zNT2wzZBp8jWPcP_nbxb1KGX_i4F2K22uHfvaUU_RHTvyEq9PweYqrFhg
CitedBy_id crossref_primary_10_3919_jjsa_70_1864
crossref_primary_10_3919_jjsa_73_2409
crossref_primary_10_3919_jjsa_70_233
crossref_primary_10_3919_jjsa_71_2464
crossref_primary_10_5795_jjscc_49_25
crossref_primary_10_3919_jjsa_71_2980
crossref_primary_10_3919_jjsa_76_608
crossref_primary_10_1136_jcp_2007_047720
crossref_primary_10_1136_jcp_2008_058693
crossref_primary_10_3919_jjsa_73_699
Cites_doi 10.1136/ijgc-00009577-200311000-00006
10.1097/00000478-200308000-00001
10.3919/jjsa.64.2905
10.1007/BF02165856
10.1093/ajcp/75.5.734
10.1046/j.1365-2559.2002.01352.x
10.3919/jjsa.61.1309
10.1055/s-2007-1005704
10.1046/j.1365-2559.2000.00770.x
10.2214/ajr.138.3.531
10.1002/1097-0142(19900915)66:6<1091::AID-CNCR2820660602>3.0.CO;2-F
10.5833/jjgs.34.1552
10.1097/00004728-198601000-00013
10.1006/gyno.1996.0060
10.5833/jjgs.35.1749
10.1046/j.1365-2559.2001.01157.x
10.1007/BF03032393
10.5833/jjgs.36.1321
10.1053/crad.2001.0790
10.1007/s00261-003-0038-6
ContentType Journal Article
Copyright 2005 by The Japanese Society of Internal Medicine
2005 INIST-CNRS
Copyright_xml – notice: 2005 by The Japanese Society of Internal Medicine
– notice: 2005 INIST-CNRS
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ADTOC
UNPAY
DOI 10.2169/internalmedicine.44.944
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Unpaywall for CDI: Periodical Content
Unpaywall
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: UNPAY
  name: Unpaywall
  url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1349-7235
EndPage 948
ExternalDocumentID 10.2169/internalmedicine.44.944
16258208
17226221
10_2169_internalmedicine_44_944
article_internalmedicine_44_9_44_9_944_article_char_en
Genre Journal Article
Case Reports
GroupedDBID ---
.55
29J
2WC
3O-
53G
5GY
ACPRK
ADBBV
ADRAZ
AENEX
AFRAH
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
CS3
DIK
DU5
EBS
EJD
EMOBN
F5P
HYE
JSF
JSH
M48
OK1
OVT
P2P
PGMZT
RJT
RNS
RPM
RZJ
TKC
TR2
X7M
XSB
AAYXX
CITATION
IQODW
7.U
CGR
CUY
CVF
ECM
EIF
M~E
NPM
7X8
ADTOC
UNPAY
ID FETCH-LOGICAL-c606t-700997169ae3ccf5f7655a49adfd2cb485fe2f873e04a276ed71ae7380e57e3f3
IEDL.DBID UNPAY
ISSN 0918-2918
1349-7235
IngestDate Tue Aug 19 23:21:39 EDT 2025
Thu Oct 02 06:54:55 EDT 2025
Sat Sep 28 08:42:37 EDT 2024
Mon Jul 21 09:17:25 EDT 2025
Tue Jul 01 03:23:35 EDT 2025
Thu Apr 24 22:59:02 EDT 2025
Wed Sep 03 06:11:38 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 9
Keywords Antineoplastic agent
Case study
Human
Immunohistochemistry
Anatomic pathology
Chemotherapy
Papillary adenocarcinoma
Treatment
Internal medicine
Abdominal disease
Malignant tumor
Peritoneum
Language English
License CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c606t-700997169ae3ccf5f7655a49adfd2cb485fe2f873e04a276ed71ae7380e57e3f3
Notes ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
OpenAccessLink https://proxy.k.utb.cz/login?url=https://www.jstage.jst.go.jp/article/internalmedicine/44/9/44_9_944/_pdf
PMID 16258208
PQID 68746504
PQPubID 23479
PageCount 5
ParticipantIDs unpaywall_primary_10_2169_internalmedicine_44_944
proquest_miscellaneous_68746504
pubmed_primary_16258208
pascalfrancis_primary_17226221
crossref_primary_10_2169_internalmedicine_44_944
crossref_citationtrail_10_2169_internalmedicine_44_944
jstage_primary_article_internalmedicine_44_9_44_9_944_article_char_en
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2005-09-01
PublicationDateYYYYMMDD 2005-09-01
PublicationDate_xml – month: 09
  year: 2005
  text: 2005-09-01
  day: 01
PublicationDecade 2000
PublicationPlace Tokyo
PublicationPlace_xml – name: Tokyo
– name: Japan
PublicationTitle Internal Medicine
PublicationTitleAlternate Intern. Med.
PublicationYear 2005
Publisher The Japanese Society of Internal Medicine
Japanese Society of Internal Medicine
Publisher_xml – name: The Japanese Society of Internal Medicine
– name: Japanese Society of Internal Medicine
References 25) Ransom DT, Patel SR, Keeney GL, Malkasian GD, Edmonson JH. Papillary serous carcinoma of the peritoneum: a review of 33 cases treated with platin-based chemotherapy. Cancer 66: 1091-1094, 1990.
26) Ben-Baruch G, Sivan E, Moran O, Rizel S, Menczer J, Seidman DS. Primary peritoneal serous papillary carcinoma: a study of 25 cases and comparison with stage III-IV ovarian papillary serous carcinoma. Gynecol Oncol 60: 393-396, 1996.
19) Ordonez NG. The immunohistochemical diagnosis of mesothelioma. Am J Surg Pathol 27: 1031-1051, 2003.
2) Feuer GA, Shevchuk M, Calanog A. Normal sized ovary carcinoma syndrome. Obstet Gynecol 73: 786-792, 1989.
27) Look M, Chang D, Sugarbaker PH. Long-term results of cytoreductive surgery for advanced and recurrent epithelial ovarian cancers and papillary serous carcinoma of the peritoneum. Int J Gynecol Cancer 13: 764-770, 2003.
1) Hsu SM, Raine L, Anger H. A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies. Am J Clin Pathol 75: 734-738, 1981.
3) Toyonaga T, Matsuo K, Yamaguchi H, et al. A case of serous papillary adenocarcinoma of the retroperitoneum. Shoukakigeka 23: 1325-1330, 2000 (in Japanese).
15) Whitley NO, Brenner DE, Antman KH, Grant D, Aisner J. CT of peritoneal mesothelioma: analysis of eight cases. Am J Roentgenol 138: 531-535, 1982.
18) Trauner M, Klimpfinger M, Stauber RE, Schreiber F, Stoger H, Krejs GJ. Laparoscopic diagnosis of peritoneal serous papillary carcinoma. Endoscopy 27: 337-341, 1995.
4) Kamiya S, Terasaki M, Okamoto Y, et al. A case of peritoneal serous papillary carcinoma. Nippon Rinsho Geka Gakkai Zassi 61: 1309-1314, 2000 (in Japanese).
20) Oates J, Edwards C. HBME-1, MOC-31, WT1 and calretinin: an assessment of recently described markers for mesothelioma and adenocarcinoma. Histopathology 36: 341-347, 2000.
8) Hara Y, Kareyama H, Sakai K, et al. Clinical analysis of peritoneal serous surface papillary carcinoma. Acta Obst Gynaec Jpn 52: 626-630, 2000 (in Japanese
6) Yamazaki T, Hatano H, Suzuki A, et al. Normal-sized ovary carcinoma syndrome: histopathological analysis of 14 cases. Nippon Sanka Fujinka Gakkai Zassi 47: 27-34, 1995 (in Japanese).
21) Gumurdulu D, Zeren EH, Cagle PT, et al. Specificity of MOC-31 and HBME-1 immunohistochemistry in the differential diagnosis of adenocarcinoma and malignant mesothelioma: a study on environmental malignant mesothelioma cases from Turkish villages. Pathol Oncol Res 8: 188-193, 2002.
7) Onisi I, Kamata T, Hayashi H, et al. A case of peritoneal serous papillary adenocarcinoma. Jpn J Gastroenterol Surg 34: 1552-1555, 2001 (in Japanese).
17) Cooper C, Jeffrey RB, Silverman PM, Federle MP, Chun GH. Computed tomography of omental pathology. J Comput Assist Tomogr 10: 62-66, 1986.
10) Konishi M, Yoshida M, Koshiyama M, et al. Primary treatment for 6 patients with carcinoma of presumably primary peritoneal origin. Adv Obstet Gynecol 50: 195-200, 1998 (in Japanese).
11) Sunami T, Kanemura S, Ohira M, You T. A case of peritoneal serous papillary adenocarcinoma. Jpn J Gastroenterol Surg 36: 1321-1326, 2003 (in Japanese).
13) Kebapci M, Yalcin OT, Dundar E, Ozalp SS, Kaya T. Computed tomography findings of primary serous papillary carcinoma of the peritoneum in women. Eur J Gynaecol Oncol 24: 552-556, 2003.
22) Gonzalez-Lois C, Ballestin C, Sotelo MT, Lopez-Rios F, Garcia-Prats MD, Villena V. Combined use of novel epithelial (MOC-31) and mesothelial (HBME-1) immunohistochemical markers for optimal first line diagnostic distinction between mesothelioma and metastatic carcinoma in pleura. Histopathology 38: 528-534, 2001.
23) Attanoos RL, Webb R, Dojcinov SD, Gibbs AR. Value of mesothelial and epithelial antibodies in distinguishing diffuse peritoneal mesothelioma in females from serous papillary carcinoma of the ovary and peritoneum. Histopathology 40: 237-244, 2002.
9) Ueda K, Kawai T, Kobayashi Y, Usui Y, Higashi R, Nomura S. A case of serous papillary adenocarcinoma. Nippon Rinsho Geka Gakkai Zassi 64: 2905-2908, 2003 (in Japanese).
12) Zissin R, Hertz M, Shapiro-Feinberg M, Bernheim J, Altaras M, Fishman A. Primary serous papillary carcinoma of the peritoneum: CT findings. Clin Radiol 56: 740-745, 2001.
16) Smith TR. Malignant peritoneal mesothelioma: marked variability of CT findings. Abdom Imaging 19: 27-29, 1994.
24) Taus P, Petru E, Gucer F, Pickel H, Lahousen M. Primary serous papillary carcinoma of the peritoneum: a report of 18 patients. Eur J Gynaec Oncol 18: 171-172, 1997.
14) Chiou SY, Sheu MH, Wang JH, Chang CY. Peritoneal serous papillary carcinoma: a reappraisal of CT imaging features and literature review. Abdom Imaging 28: 815-819, 2003.
5) Hasegawa K, Kamano N, Ogura T, et al. A case of extraovarian peritoneal serous papillary carcinoma. Jpn J Gastroenterol Surg 35: 1749-1753, 2002 (in Japanese).
22
23
24
25
26
27
10
11
12
13
14
15
16
17
18
19
1
2
3
4
5
6
7
8
9
20
21
References_xml – reference: 9) Ueda K, Kawai T, Kobayashi Y, Usui Y, Higashi R, Nomura S. A case of serous papillary adenocarcinoma. Nippon Rinsho Geka Gakkai Zassi 64: 2905-2908, 2003 (in Japanese).
– reference: 2) Feuer GA, Shevchuk M, Calanog A. Normal sized ovary carcinoma syndrome. Obstet Gynecol 73: 786-792, 1989.
– reference: 20) Oates J, Edwards C. HBME-1, MOC-31, WT1 and calretinin: an assessment of recently described markers for mesothelioma and adenocarcinoma. Histopathology 36: 341-347, 2000.
– reference: 13) Kebapci M, Yalcin OT, Dundar E, Ozalp SS, Kaya T. Computed tomography findings of primary serous papillary carcinoma of the peritoneum in women. Eur J Gynaecol Oncol 24: 552-556, 2003.
– reference: 7) Onisi I, Kamata T, Hayashi H, et al. A case of peritoneal serous papillary adenocarcinoma. Jpn J Gastroenterol Surg 34: 1552-1555, 2001 (in Japanese).
– reference: 4) Kamiya S, Terasaki M, Okamoto Y, et al. A case of peritoneal serous papillary carcinoma. Nippon Rinsho Geka Gakkai Zassi 61: 1309-1314, 2000 (in Japanese).
– reference: 26) Ben-Baruch G, Sivan E, Moran O, Rizel S, Menczer J, Seidman DS. Primary peritoneal serous papillary carcinoma: a study of 25 cases and comparison with stage III-IV ovarian papillary serous carcinoma. Gynecol Oncol 60: 393-396, 1996.
– reference: 18) Trauner M, Klimpfinger M, Stauber RE, Schreiber F, Stoger H, Krejs GJ. Laparoscopic diagnosis of peritoneal serous papillary carcinoma. Endoscopy 27: 337-341, 1995.
– reference: 3) Toyonaga T, Matsuo K, Yamaguchi H, et al. A case of serous papillary adenocarcinoma of the retroperitoneum. Shoukakigeka 23: 1325-1330, 2000 (in Japanese).
– reference: 19) Ordonez NG. The immunohistochemical diagnosis of mesothelioma. Am J Surg Pathol 27: 1031-1051, 2003.
– reference: 8) Hara Y, Kareyama H, Sakai K, et al. Clinical analysis of peritoneal serous surface papillary carcinoma. Acta Obst Gynaec Jpn 52: 626-630, 2000 (in Japanese)
– reference: 21) Gumurdulu D, Zeren EH, Cagle PT, et al. Specificity of MOC-31 and HBME-1 immunohistochemistry in the differential diagnosis of adenocarcinoma and malignant mesothelioma: a study on environmental malignant mesothelioma cases from Turkish villages. Pathol Oncol Res 8: 188-193, 2002.
– reference: 17) Cooper C, Jeffrey RB, Silverman PM, Federle MP, Chun GH. Computed tomography of omental pathology. J Comput Assist Tomogr 10: 62-66, 1986.
– reference: 6) Yamazaki T, Hatano H, Suzuki A, et al. Normal-sized ovary carcinoma syndrome: histopathological analysis of 14 cases. Nippon Sanka Fujinka Gakkai Zassi 47: 27-34, 1995 (in Japanese).
– reference: 12) Zissin R, Hertz M, Shapiro-Feinberg M, Bernheim J, Altaras M, Fishman A. Primary serous papillary carcinoma of the peritoneum: CT findings. Clin Radiol 56: 740-745, 2001.
– reference: 27) Look M, Chang D, Sugarbaker PH. Long-term results of cytoreductive surgery for advanced and recurrent epithelial ovarian cancers and papillary serous carcinoma of the peritoneum. Int J Gynecol Cancer 13: 764-770, 2003.
– reference: 1) Hsu SM, Raine L, Anger H. A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies. Am J Clin Pathol 75: 734-738, 1981.
– reference: 15) Whitley NO, Brenner DE, Antman KH, Grant D, Aisner J. CT of peritoneal mesothelioma: analysis of eight cases. Am J Roentgenol 138: 531-535, 1982.
– reference: 23) Attanoos RL, Webb R, Dojcinov SD, Gibbs AR. Value of mesothelial and epithelial antibodies in distinguishing diffuse peritoneal mesothelioma in females from serous papillary carcinoma of the ovary and peritoneum. Histopathology 40: 237-244, 2002.
– reference: 10) Konishi M, Yoshida M, Koshiyama M, et al. Primary treatment for 6 patients with carcinoma of presumably primary peritoneal origin. Adv Obstet Gynecol 50: 195-200, 1998 (in Japanese).
– reference: 5) Hasegawa K, Kamano N, Ogura T, et al. A case of extraovarian peritoneal serous papillary carcinoma. Jpn J Gastroenterol Surg 35: 1749-1753, 2002 (in Japanese).
– reference: 14) Chiou SY, Sheu MH, Wang JH, Chang CY. Peritoneal serous papillary carcinoma: a reappraisal of CT imaging features and literature review. Abdom Imaging 28: 815-819, 2003.
– reference: 24) Taus P, Petru E, Gucer F, Pickel H, Lahousen M. Primary serous papillary carcinoma of the peritoneum: a report of 18 patients. Eur J Gynaec Oncol 18: 171-172, 1997.
– reference: 11) Sunami T, Kanemura S, Ohira M, You T. A case of peritoneal serous papillary adenocarcinoma. Jpn J Gastroenterol Surg 36: 1321-1326, 2003 (in Japanese).
– reference: 25) Ransom DT, Patel SR, Keeney GL, Malkasian GD, Edmonson JH. Papillary serous carcinoma of the peritoneum: a review of 33 cases treated with platin-based chemotherapy. Cancer 66: 1091-1094, 1990.
– reference: 16) Smith TR. Malignant peritoneal mesothelioma: marked variability of CT findings. Abdom Imaging 19: 27-29, 1994.
– reference: 22) Gonzalez-Lois C, Ballestin C, Sotelo MT, Lopez-Rios F, Garcia-Prats MD, Villena V. Combined use of novel epithelial (MOC-31) and mesothelial (HBME-1) immunohistochemical markers for optimal first line diagnostic distinction between mesothelioma and metastatic carcinoma in pleura. Histopathology 38: 528-534, 2001.
– ident: 2
– ident: 27
  doi: 10.1136/ijgc-00009577-200311000-00006
– ident: 19
  doi: 10.1097/00000478-200308000-00001
– ident: 9
  doi: 10.3919/jjsa.64.2905
– ident: 16
  doi: 10.1007/BF02165856
– ident: 1
  doi: 10.1093/ajcp/75.5.734
– ident: 10
– ident: 23
  doi: 10.1046/j.1365-2559.2002.01352.x
– ident: 4
  doi: 10.3919/jjsa.61.1309
– ident: 18
  doi: 10.1055/s-2007-1005704
– ident: 20
  doi: 10.1046/j.1365-2559.2000.00770.x
– ident: 15
  doi: 10.2214/ajr.138.3.531
– ident: 24
– ident: 25
  doi: 10.1002/1097-0142(19900915)66:6<1091::AID-CNCR2820660602>3.0.CO;2-F
– ident: 3
– ident: 7
  doi: 10.5833/jjgs.34.1552
– ident: 17
  doi: 10.1097/00004728-198601000-00013
– ident: 26
  doi: 10.1006/gyno.1996.0060
– ident: 5
  doi: 10.5833/jjgs.35.1749
– ident: 22
  doi: 10.1046/j.1365-2559.2001.01157.x
– ident: 13
– ident: 21
  doi: 10.1007/BF03032393
– ident: 11
  doi: 10.5833/jjgs.36.1321
– ident: 12
  doi: 10.1053/crad.2001.0790
– ident: 6
– ident: 8
– ident: 14
  doi: 10.1007/s00261-003-0038-6
SSID ssj0038792
Score 1.7033392
Snippet We report four cases of peritoneal serous papillary adenocarcinoma (PSPC), a rare disease; all patients had ascites and high levels of serum CA125. Clinical...
SourceID unpaywall
proquest
pubmed
pascalfrancis
crossref
jstage
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 944
SubjectTerms Adult
Aged
Biological and medical sciences
Biomarkers, Tumor - metabolism
CA-125 Antigen - metabolism
chemotherapy
Cystadenocarcinoma, Papillary - diagnosis
Cystadenocarcinoma, Papillary - metabolism
Cystadenocarcinoma, Papillary - pathology
Diagnosis, Differential
Female
General aspects
Humans
Immunohistochemistry
Medical sciences
Mesothelioma - diagnosis
Middle Aged
Peritoneal Neoplasms - diagnosis
Peritoneal Neoplasms - metabolism
Peritoneal Neoplasms - pathology
peritoneum
Prognosis
Title Peritoneal Serous Papillary Adenocarcinoma: Report of Four Cases
URI https://www.jstage.jst.go.jp/article/internalmedicine/44/9/44_9_944/_article/-char/en
https://www.ncbi.nlm.nih.gov/pubmed/16258208
https://www.proquest.com/docview/68746504
https://www.jstage.jst.go.jp/article/internalmedicine/44/9/44_9_944/_pdf
UnpaywallVersion publishedVersion
Volume 44
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Internal Medicine, 2005, Vol.44(9), pp.944-948
journalDatabaseRights – providerCode: PRVBFR
  databaseName: Free Medical Journals - Free Access to All
  customDbUrl:
  eissn: 1349-7235
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0038792
  issn: 1349-7235
  databaseCode: DIK
  dateStart: 19920101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwEB6VLQJ64F0IjyUHrsluHD-SnlhVXS2gVntgpXKyHMeuWra70T5Utb-ecZxsaakEQlySHDyOMzOxv7HHnwE-OgZ0yy2LMjd9T4XWUa41iTRBrEGVYly4vcOHR3w0oV-O2fEWjNq9MC6t8gxx0Ylxt_hkHp9VvUaJvVM_STZtl517lPZyvMhc5vgoq9Leg23OEJV3YHtyNB58r6n2ErfRoJ7qc2R8kSAp86leJOH5b7XGlMZY3Y2B6r5vk8ucVEtUnvWnXtwFS3fg4XpWqcsLNZ3-MlQNn8Bp-5E-Q-VHvF4Vsb66xf_4P7TwFB43eDYceKlnsGVmz-HBYSP0Aj6N0cUd4TcWwn5pvl6GY1W5o44Wl-EAOz0cSxdYdH6u9kIfDYRzGw6x3nAfR9jlS5gMD77tj6Lm1IZIYzC0ioQDnY6DR5lUa8us4IwpmqvSlkQXNGPWEJuJ1PSpIoKbUiTKiDTrGyZMatNd6MywWa8hJESwMqes9htDdU4LxRJuEdNYygoTAG9NJHVDae5O1phKDG2cbeVtXUmnJkoD6G8EK8_q8WeRA2-RjUBjj7sFZGuPTTG3iw67ogC6N1zo-v0CkTAhSQAfWp-S-Ku79Rs1M2geyTNBEVBjU155V7uWxSgWoVwWQLLxvb_9sDf_IPMWHtUUtnWu3TvorBZr8x7B2aroYljy-Wu3-ft-Agn3QgQ
linkProvider Unpaywall
linkToUnpaywall http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LT9wwEB7RpSrtAfoC0gfNoddkN44fSU9dIVarSqA9sBI9WY5jI-h2N9qHEP31jONkKRSpFeolycHj2DNj-7M9_gzw2TGgW25ZlLnleyq0jnKtSaQJYg2qFOPCnR0-PuHDMf12xs42YNiehXFhlZeIi86Ne8Xns_iy6jZK7F74RbJJu-3cpbSb40PmMsdPWZX2CWxyhqi8A5vjk1H_e021l7iDBvVSnyPjiwRJmQ_1IgnP_8g1pjTG7O4MVE99mVzkpFqg8qy_9eIhWPoCtlbTSl1fqcnkt6FqsAMXbSV9hMqPeLUsYv3rHv_j_9DCS9hu8GzY91KvYMNMX8Oz40boDXwdoYs7wm9MhP3SbLUIR6pyVx3Nr8M-dno4ls4x6eyn-hL62UA4s-EA8w0PcYRdvIXx4Oj0cBg1tzZEGidDy0g40Ok4eJRJtbbMCs6YorkqbUl0QTNmDbGZSE2PKiK4KUWijEiznmHCpDbdhc4Ui7UPISGClTlltd8YqnNaKJZwi5jGUlaYAHhrIqkbSnN3s8ZE4tTG2Vbe15V0aqI0gN5asPKsHn8XOfIWWQs09nhYQLb2WCdzp-iwKwrg4I4L3f5fIBImJAngU-tTEpu6279RU4PmkTwTFAE1FmXPu9qtLM5iEcplASRr3_vXir17hMx7eF5T2Naxdh-gs5yvzEcEZ8vioGl3N4OGQQs
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Peritoneal+Serous+Papillary+Adenocarcinoma%3A+Report+of+Four+Cases&rft.jtitle=Internal+medicine+%28Tokyo%2C+1992%29&rft.au=MINAMI%2C+Takeshi&rft.au=NAKATANI%2C+Koji&rft.au=KONDO%2C+Shinya&rft.au=KANAYAMA%2C+Shuji&rft.date=2005-09-01&rft.issn=0918-2918&rft.eissn=1349-7235&rft.volume=44&rft.issue=9&rft.spage=944&rft.epage=948&rft_id=info:doi/10.2169%2Finternalmedicine.44.944&rft.externalDBID=n%2Fa&rft.externalDocID=10_2169_internalmedicine_44_944
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0918-2918&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0918-2918&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0918-2918&client=summon